Paramount prognostic factors that guide therapeutic strategies in diffuse large B-cell lymphoma.
Sehn, Laurie H
Paramount prognostic factors that guide therapeutic strategies in diffuse large B-cell lymphoma. [electronic resource] - Hematology. American Society of Hematology. Education Program 2012 - 402-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1520-4383
10.1182/asheducation-2012.1.402 doi
Aged
Antibodies, Monoclonal, Murine-Derived--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers, Tumor
Clinical Trials as Topic
Cyclophosphamide--therapeutic use
Doxorubicin--therapeutic use
Female
Gene Expression Profiling
Humans
Lymphoma, Large B-Cell, Diffuse--blood
Male
Medical Oncology--methods
Middle Aged
Prednisone--therapeutic use
Prognosis
Rituximab
Time Factors
Treatment Outcome
Vincristine--therapeutic use
Paramount prognostic factors that guide therapeutic strategies in diffuse large B-cell lymphoma. [electronic resource] - Hematology. American Society of Hematology. Education Program 2012 - 402-9 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
1520-4383
10.1182/asheducation-2012.1.402 doi
Aged
Antibodies, Monoclonal, Murine-Derived--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Biomarkers, Tumor
Clinical Trials as Topic
Cyclophosphamide--therapeutic use
Doxorubicin--therapeutic use
Female
Gene Expression Profiling
Humans
Lymphoma, Large B-Cell, Diffuse--blood
Male
Medical Oncology--methods
Middle Aged
Prednisone--therapeutic use
Prognosis
Rituximab
Time Factors
Treatment Outcome
Vincristine--therapeutic use